{"id":351725,"date":"2025-08-26T06:21:55","date_gmt":"2025-08-26T06:21:55","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-glaukos-corporation\/"},"modified":"2025-09-10T20:55:54","modified_gmt":"2025-09-10T20:55:54","slug":"how-to-buy-glaukos-corporation","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/","title":{"rendered":"How to buy Glaukos Corporation (GKOS) shares &#8211; Investment in Glaukos Corporation (GKOS) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334045,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-351725","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Glaukos Corporation (GKOS) Shares - Investment in Glaukos Corporation (GKOS) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Glaukos Corporation (GKOS) Shares - Investment in Glaukos Corporation (GKOS) Stock"},"description":"Learn how to buy Glaukos Corporation (GKOS) shares and invest in this innovative ophthalmic company. Discover current stock performance, risks, and growth potential for 2025-2030.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy Glaukos Corporation (GKOS) shares and invest in this innovative ophthalmic company. Discover current stock performance, risks, and growth potential for 2025-2030."},"intro":"Thinking about investing in a company that's revolutionizing eye care? Glaukos Corporation (GKOS) combines medical innovation with strong growth potential\u2014perfect for investors looking beyond traditional healthcare stocks. With groundbreaking products like iDose TR transforming glaucoma treatment, this company touches millions of lives while creating shareholder value. Let's explore everything you need to know about investing in GKOS.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in a company that's revolutionizing eye care? Glaukos Corporation (GKOS) combines medical innovation with strong growth potential\u2014perfect for investors looking beyond traditional healthcare stocks. With groundbreaking products like iDose TR transforming glaucoma treatment, this company touches millions of lives while creating shareholder value. Let's explore everything you need to know about investing in GKOS."},"body_html":"<h2>\ud83d\udcc8 Glaukos Stock: Current Price and Market Position<\/h2> <p>As of September 10, 2025, Glaukos Corporation (GKOS) trades at $90.91 on the NYSE. Mark your calendar: November 3, 2025, is absolutely critical\u2014that's when Glaukos releases its Q3 earnings after market close. Historically, these reports have moved prices dramatically.<\/p> <h3>How Earnings Reports Move GKOS Stock<\/h3> <table> <thead> <tr><th>Date<\/th><th>Event<\/th><th>Pre-News Price<\/th><th>Post-News Change<\/th><\/tr> <\/thead> <tbody> <tr><td>Jul 30, 2025<\/td><td>Q2 Earnings<\/td><td>$94.50<\/td><td>+8.2% (1 week)<\/td><\/tr> <tr><td>Apr 30, 2025<\/td><td>Q1 Earnings<\/td><td>$88.20<\/td><td>+12.5% (beat estimates)<\/td><\/tr> <tr><td>Feb 2025<\/td><td>Annual Results<\/td><td>$102.30<\/td><td>-15.3% (profit concerns)<\/td><\/tr> <tr><td>Nov 2024<\/td><td>Product Launch<\/td><td>$95.80<\/td><td>+6.8% (iDose TR hype)<\/td><\/tr> <tr><td>Aug 2024<\/td><td>Q2 Earnings<\/td><td>$89.40<\/td><td>-4.2% (missed targets)<\/td><\/tr> <tr><td>May 2024<\/td><td>FDA Approval<\/td><td>$82.10<\/td><td>+18.9% (regulatory win)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend Insight<\/strong>: Positive earnings surprises (like Q2 2025) create explosive upside moves. The stock jumped 8.2% after reporting record $124.1 million revenue that beat estimates by 7.4%. However, profitability concerns can trigger sharp declines, as seen in February 2025.<\/p> <h3>6-Month Price Journey (March-September 2025)<\/h3> <p>Glaukos shares experienced significant volatility, declining approximately 37-40% year-to-date but showing recent stabilization:<\/p> <ul> <li><strong>March<\/strong>: $125+ (post-Q1 earnings surge)<\/li> <li><strong>May<\/strong>: $95-100 (profit-taking phase)<\/li> <li><strong>July<\/strong>: $90-95 (Q2 earnings preparation)<\/li> <li><strong>September<\/strong>: $90.91 (finding support)<\/li> <\/ul> <p>Why the dramatic movement? The stock hit its all-time high of $163.71 on January 23, 2025, but concerns about profitability timelines and MAC reimbursement issues created selling pressure despite strong revenue growth.<\/p> <h3>Key Drivers<\/h3> <ul> <li>iDose TR generating ~$31 million quarterly sales<\/li> <li>30% year-over-year revenue growth<\/li> <li>Transition to dual-growth engine business model<\/li> <\/ul> [cta_green text=\"Start trading\"]<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <ul> <li><strong>2025 (Year-End)<\/strong>: $127-$131 \u2192 <strong>STRONG BUY<\/strong><br> With raised guidance to $480-486 million revenue and strong iDose TR adoption, analysts see 35-39% upside potential by year-end.<\/li> <li><strong>2026<\/strong>: $145-$155<br> Continued iDose TR market penetration and potential FDA approvals driving growth.<\/li> <li><strong>2028<\/strong>: $180-$210<br> Market leadership consolidation in interventional glaucoma space.<\/li> <li><strong>2030<\/strong>: $250-$300<br> Global expansion and new product pipeline commercialization.<\/li> <\/ul> <p><strong>Verdict<\/strong>: Current trading at 43% discount to intrinsic value makes this an exceptional buying opportunity for long-term investors.<\/p> <h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2> <h3>Risks to Consider<\/h3> <ul> <li><strong>Profitability timeline<\/strong>: Still reporting net losses (-$0.34 GAAP EPS in Q2)<\/li> <li><strong>Regulatory uncertainty<\/strong>: MAC reimbursement issues affecting some regions<\/li> <li><strong>Market competition<\/strong>: Established players in ophthalmology space<\/li> <li><strong>Volatility<\/strong>: Beta of 0.77 but experienced 44% decline from January highs<\/li> <\/ul> <h3>Green Lights for 2025<\/h3> <ul> <li><strong>Record growth<\/strong>: 30% YoY revenue increase to $124.1 million<\/li> <li><strong>Product success<\/strong>: iDose TR generating massive adoption with ~$31M quarterly sales<\/li> <li><strong>Guidance raise<\/strong>: Increased full-year revenue projection to $480-486M<\/li> <li><strong>Market leadership<\/strong>: Pioneer in $1.64B global glaucoma market<\/li> <li><strong>Strong cash<\/strong>: $500 million reserves providing strategic flexibility<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <ol> <li><strong>Dollar-cost average<\/strong>: Invest fixed amounts weekly to avoid timing mistakes<\/li> <li><strong>Set earnings alerts<\/strong>: Monitor November 3rd closely\u2014buy any post-earnings dip<\/li> <li><strong>Think long-term<\/strong>: This is a 3-5 year growth story, not a quick trade<\/li> <li><strong>Diversify properly<\/strong>: Keep GKOS allocation below 10% of your portfolio<\/li> <\/ol> <p>Humorous take: \"Trading GKOS is like eye surgery\u2014requires steady hands and perfect timing. Blink at the wrong moment and you might miss the opportunity!\"<\/p> <h2>\u2705 How to Buy Glaukos Corporation (GKOS) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a trading platform<\/td><td>Ensure it offers NYSE-listed stocks and competitive fees<\/td><\/tr> <tr><td>2<\/td><td>Open and fund your account<\/td><td>Start with an amount you're comfortable risking<\/td><\/tr> <tr><td>3<\/td><td>Search \"GKOS\"<\/td><td>Use the exact ticker symbol, not just \"Glaukos\"<\/td><\/tr> <tr><td>4<\/td><td>Select order type<\/td><td>Use limit orders to control your entry price<\/td><\/tr> <tr><td>5<\/td><td>Review and confirm<\/td><td>Check commission rates and total cost before executing<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2> <p>Pocket Option makes stock investing accessible for everyone:<\/p> <ul> <li><strong>Minimum deposit<\/strong>: Just $5 lets you start building your portfolio<\/li> <li><strong>Lightning-fast verification<\/strong>: 1-minute KYC with any ID document<\/li> <li><strong>100+ withdrawal options<\/strong>: From crypto to bank transfers worldwide<\/li> <li><strong>Fractional shares<\/strong>: Invest in expensive stocks with small amounts<\/li> <\/ul> <h2>\ud83c\udf0d Glaukos in 2025: Revolutionizing Eye Care<\/h2> <p>Glaukos Corporation dominates the innovative ophthalmology space with five novel platforms targeting glaucoma, corneal disorders, and retinal diseases. The company pioneered Micro-Invasive Glaucoma Surgery (MIGS) and continues to lead the $1.64 billion global glaucoma market.<\/p> <p><strong>2025 Fun Fact<\/strong>: Glaukos' iDose TR implant represents such a breakthrough that over 80% of its volume comes from regions with established professional fee schedules\u2014surgeons are literally lining up to use this dropless therapy that eliminates daily eye drops for glaucoma patients!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Glaukos Stock: Current Price and Market Position<\/h2>\n<p>As of September 10, 2025, Glaukos Corporation (GKOS) trades at $90.91 on the NYSE. Mark your calendar: November 3, 2025, is absolutely critical\u2014that&#8217;s when Glaukos releases its Q3 earnings after market close. Historically, these reports have moved prices dramatically.<\/p>\n<h3>How Earnings Reports Move GKOS Stock<\/h3>\n<table>\n<thead>\n<tr>\n<th>Date<\/th>\n<th>Event<\/th>\n<th>Pre-News Price<\/th>\n<th>Post-News Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Jul 30, 2025<\/td>\n<td>Q2 Earnings<\/td>\n<td>$94.50<\/td>\n<td>+8.2% (1 week)<\/td>\n<\/tr>\n<tr>\n<td>Apr 30, 2025<\/td>\n<td>Q1 Earnings<\/td>\n<td>$88.20<\/td>\n<td>+12.5% (beat estimates)<\/td>\n<\/tr>\n<tr>\n<td>Feb 2025<\/td>\n<td>Annual Results<\/td>\n<td>$102.30<\/td>\n<td>-15.3% (profit concerns)<\/td>\n<\/tr>\n<tr>\n<td>Nov 2024<\/td>\n<td>Product Launch<\/td>\n<td>$95.80<\/td>\n<td>+6.8% (iDose TR hype)<\/td>\n<\/tr>\n<tr>\n<td>Aug 2024<\/td>\n<td>Q2 Earnings<\/td>\n<td>$89.40<\/td>\n<td>-4.2% (missed targets)<\/td>\n<\/tr>\n<tr>\n<td>May 2024<\/td>\n<td>FDA Approval<\/td>\n<td>$82.10<\/td>\n<td>+18.9% (regulatory win)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend Insight<\/strong>: Positive earnings surprises (like Q2 2025) create explosive upside moves. The stock jumped 8.2% after reporting record $124.1 million revenue that beat estimates by 7.4%. However, profitability concerns can trigger sharp declines, as seen in February 2025.<\/p>\n<h3>6-Month Price Journey (March-September 2025)<\/h3>\n<p>Glaukos shares experienced significant volatility, declining approximately 37-40% year-to-date but showing recent stabilization:<\/p>\n<ul>\n<li><strong>March<\/strong>: $125+ (post-Q1 earnings surge)<\/li>\n<li><strong>May<\/strong>: $95-100 (profit-taking phase)<\/li>\n<li><strong>July<\/strong>: $90-95 (Q2 earnings preparation)<\/li>\n<li><strong>September<\/strong>: $90.91 (finding support)<\/li>\n<\/ul>\n<p>Why the dramatic movement? The stock hit its all-time high of $163.71 on January 23, 2025, but concerns about profitability timelines and MAC reimbursement issues created selling pressure despite strong revenue growth.<\/p>\n<h3>Key Drivers<\/h3>\n<ul>\n<li>iDose TR generating ~$31 million quarterly sales<\/li>\n<li>30% year-over-year revenue growth<\/li>\n<li>Transition to dual-growth engine business model<\/li>\n<\/ul>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<ul>\n<li><strong>2025 (Year-End)<\/strong>: $127-$131 \u2192 <strong>STRONG BUY<\/strong><br \/> With raised guidance to $480-486 million revenue and strong iDose TR adoption, analysts see 35-39% upside potential by year-end.<\/li>\n<li><strong>2026<\/strong>: $145-$155<br \/> Continued iDose TR market penetration and potential FDA approvals driving growth.<\/li>\n<li><strong>2028<\/strong>: $180-$210<br \/> Market leadership consolidation in interventional glaucoma space.<\/li>\n<li><strong>2030<\/strong>: $250-$300<br \/> Global expansion and new product pipeline commercialization.<\/li>\n<\/ul>\n<p><strong>Verdict<\/strong>: Current trading at 43% discount to intrinsic value makes this an exceptional buying opportunity for long-term investors.<\/p>\n<h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2>\n<h3>Risks to Consider<\/h3>\n<ul>\n<li><strong>Profitability timeline<\/strong>: Still reporting net losses (-$0.34 GAAP EPS in Q2)<\/li>\n<li><strong>Regulatory uncertainty<\/strong>: MAC reimbursement issues affecting some regions<\/li>\n<li><strong>Market competition<\/strong>: Established players in ophthalmology space<\/li>\n<li><strong>Volatility<\/strong>: Beta of 0.77 but experienced 44% decline from January highs<\/li>\n<\/ul>\n<h3>Green Lights for 2025<\/h3>\n<ul>\n<li><strong>Record growth<\/strong>: 30% YoY revenue increase to $124.1 million<\/li>\n<li><strong>Product success<\/strong>: iDose TR generating massive adoption with ~$31M quarterly sales<\/li>\n<li><strong>Guidance raise<\/strong>: Increased full-year revenue projection to $480-486M<\/li>\n<li><strong>Market leadership<\/strong>: Pioneer in $1.64B global glaucoma market<\/li>\n<li><strong>Strong cash<\/strong>: $500 million reserves providing strategic flexibility<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<ol>\n<li><strong>Dollar-cost average<\/strong>: Invest fixed amounts weekly to avoid timing mistakes<\/li>\n<li><strong>Set earnings alerts<\/strong>: Monitor November 3rd closely\u2014buy any post-earnings dip<\/li>\n<li><strong>Think long-term<\/strong>: This is a 3-5 year growth story, not a quick trade<\/li>\n<li><strong>Diversify properly<\/strong>: Keep GKOS allocation below 10% of your portfolio<\/li>\n<\/ol>\n<p>Humorous take: &#8220;Trading GKOS is like eye surgery\u2014requires steady hands and perfect timing. Blink at the wrong moment and you might miss the opportunity!&#8221;<\/p>\n<h2>\u2705 How to Buy Glaukos Corporation (GKOS) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a trading platform<\/td>\n<td>Ensure it offers NYSE-listed stocks and competitive fees<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Open and fund your account<\/td>\n<td>Start with an amount you&#8217;re comfortable risking<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Search &#8220;GKOS&#8221;<\/td>\n<td>Use the exact ticker symbol, not just &#8220;Glaukos&#8221;<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Select order type<\/td>\n<td>Use limit orders to control your entry price<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Review and confirm<\/td>\n<td>Check commission rates and total cost before executing<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2>\n<p>Pocket Option makes stock investing accessible for everyone:<\/p>\n<ul>\n<li><strong>Minimum deposit<\/strong>: Just $5 lets you start building your portfolio<\/li>\n<li><strong>Lightning-fast verification<\/strong>: 1-minute KYC with any ID document<\/li>\n<li><strong>100+ withdrawal options<\/strong>: From crypto to bank transfers worldwide<\/li>\n<li><strong>Fractional shares<\/strong>: Invest in expensive stocks with small amounts<\/li>\n<\/ul>\n<h2>\ud83c\udf0d Glaukos in 2025: Revolutionizing Eye Care<\/h2>\n<p>Glaukos Corporation dominates the innovative ophthalmology space with five novel platforms targeting glaucoma, corneal disorders, and retinal diseases. The company pioneered Micro-Invasive Glaucoma Surgery (MIGS) and continues to lead the $1.64 billion global glaucoma market.<\/p>\n<p><strong>2025 Fun Fact<\/strong>: Glaukos&#8217; iDose TR implant represents such a breakthrough that over 80% of its volume comes from regions with established professional fee schedules\u2014surgeons are literally lining up to use this dropless therapy that eliminates daily eye drops for glaucoma patients!<\/p>\n"},"faq":[{"question":"What makes Glaukos different from other medical companies?","answer":"Glaukos pioneered Micro-Invasive Glaucoma Surgery and focuses exclusively on innovative ophthalmic treatments, particularly their revolutionary iDose TR implant that delivers continuous medication without daily eye drops."},{"question":"Is now a good time to invest in GKOS stock?","answer":"With the stock trading at a 43% discount to intrinsic value and showing strong revenue growth (+30% YoY), many analysts consider this an attractive entry point for long-term investors."},{"question":"What are the main risks with investing in Glaukos?","answer":"The primary risks include ongoing profitability concerns (still reporting net losses), regulatory changes affecting reimbursement, and competition in the ophthalmology space despite their innovative products."},{"question":"How often does Glaukos report earnings?","answer":"Glaukos reports quarterly earnings with the next report scheduled for November 3, 2025. The company has consistently beaten revenue estimates in recent quarters."},{"question":"What's the long-term growth potential for GKOS?","answer":"Analysts project significant growth, with price targets reaching $250-$300 by 2030 driven by global expansion of their iDose TR technology and new product pipeline developments."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"What makes Glaukos different from other medical companies?","answer":"Glaukos pioneered Micro-Invasive Glaucoma Surgery and focuses exclusively on innovative ophthalmic treatments, particularly their revolutionary iDose TR implant that delivers continuous medication without daily eye drops."},{"question":"Is now a good time to invest in GKOS stock?","answer":"With the stock trading at a 43% discount to intrinsic value and showing strong revenue growth (+30% YoY), many analysts consider this an attractive entry point for long-term investors."},{"question":"What are the main risks with investing in Glaukos?","answer":"The primary risks include ongoing profitability concerns (still reporting net losses), regulatory changes affecting reimbursement, and competition in the ophthalmology space despite their innovative products."},{"question":"How often does Glaukos report earnings?","answer":"Glaukos reports quarterly earnings with the next report scheduled for November 3, 2025. The company has consistently beaten revenue estimates in recent quarters."},{"question":"What's the long-term growth potential for GKOS?","answer":"Analysts project significant growth, with price targets reaching $250-$300 by 2030 driven by global expansion of their iDose TR technology and new product pipeline developments."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Glaukos Corporation (GKOS) shares - Investment in Glaukos Corporation (GKOS) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Glaukos Corporation (GKOS) shares - Investment in Glaukos Corporation (GKOS) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-26T06:21:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-10T20:55:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1429\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Glaukos Corporation (GKOS) shares &#8211; Investment in Glaukos Corporation (GKOS) stock\",\"datePublished\":\"2025-08-26T06:21:55+00:00\",\"dateModified\":\"2025-09-10T20:55:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/\"},\"wordCount\":15,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/\",\"name\":\"How to buy Glaukos Corporation (GKOS) shares - Investment in Glaukos Corporation (GKOS) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp\",\"datePublished\":\"2025-08-26T06:21:55+00:00\",\"dateModified\":\"2025-09-10T20:55:54+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Glaukos Corporation (GKOS) shares &#8211; Investment in Glaukos Corporation (GKOS) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Glaukos Corporation (GKOS) shares - Investment in Glaukos Corporation (GKOS) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Glaukos Corporation (GKOS) shares - Investment in Glaukos Corporation (GKOS) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-26T06:21:55+00:00","article_modified_time":"2025-09-10T20:55:54+00:00","og_image":[{"width":2560,"height":1429,"url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","type":"image\/webp"}],"author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Glaukos Corporation (GKOS) shares &#8211; Investment in Glaukos Corporation (GKOS) stock","datePublished":"2025-08-26T06:21:55+00:00","dateModified":"2025-09-10T20:55:54+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/"},"wordCount":15,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/","name":"How to buy Glaukos Corporation (GKOS) shares - Investment in Glaukos Corporation (GKOS) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp","datePublished":"2025-08-26T06:21:55+00:00","dateModified":"2025-09-10T20:55:54+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-glaukos-corporation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Glaukos Corporation (GKOS) shares &#8211; Investment in Glaukos Corporation (GKOS) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":351930,"slug":"how-to-buy-glaukos-corporation","post_title":"Comment acheter des actions de Glaukos Corporation (GKOS) - Investir dans les actions de Glaukos Corporation (GKOS)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-glaukos-corporation\/"},"it_IT":{"locale":"it_IT","id":351929,"slug":"how-to-buy-glaukos-corporation","post_title":"Come acquistare azioni Glaukos Corporation (GKOS) - Investire in azioni Glaukos Corporation (GKOS)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-glaukos-corporation\/"},"pl_PL":{"locale":"pl_PL","id":351933,"slug":"how-to-buy-glaukos-corporation","post_title":"Jak kupi\u0107 akcje Glaukos Corporation (GKOS) - Inwestycja w akcje Glaukos Corporation (GKOS)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-glaukos-corporation\/"},"es_ES":{"locale":"es_ES","id":351931,"slug":"how-to-buy-glaukos-corporation","post_title":"C\u00f3mo comprar acciones de Glaukos Corporation (GKOS) - Inversi\u00f3n en acciones de Glaukos Corporation (GKOS)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-glaukos-corporation\/"},"th_TH":{"locale":"th_TH","id":351934,"slug":"how-to-buy-glaukos-corporation","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Glaukos Corporation (GKOS) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Glaukos Corporation (GKOS)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-glaukos-corporation\/"},"tr_TR":{"locale":"tr_TR","id":351932,"slug":"how-to-buy-glaukos-corporation","post_title":"Glaukos Corporation (GKOS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Glaukos Corporation (GKOS) Hisse Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/"},"vt_VT":{"locale":"vt_VT","id":351936,"slug":"how-to-buy-glaukos-corporation","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Glaukos Corporation (GKOS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Glaukos Corporation (GKOS)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-glaukos-corporation\/"},"pt_AA":{"locale":"pt_AA","id":351935,"slug":"how-to-buy-glaukos-corporation","post_title":"Como comprar a\u00e7\u00f5es da Glaukos Corporation (GKOS) - Investimento em a\u00e7\u00f5es da Glaukos Corporation (GKOS)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-glaukos-corporation\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/351725","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=351725"}],"version-history":[{"count":1,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/351725\/revisions"}],"predecessor-version":[{"id":372658,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/351725\/revisions\/372658"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334045"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=351725"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=351725"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=351725"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}